{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+Intravenous&page=45", "query": { "intervention": "Placebo Intravenous", "page": 45 }, "page_size": 10 }, "pagination": { "page": 45, "page_size": 10, "total_count": 2347, "total_pages": 235, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+Intravenous&page=46&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+Intravenous&page=44&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-16T07:47:20.054Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03729362", "title": "A Study Comparing ATB200/AT2221 With Alglucosidase Alfa/Placebo in Adult Subjects With Late-onset Pompe Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pompe Disease (Late-onset)" ], "interventions": [ { "name": "Cipaglucosidase Alfa", "type": "BIOLOGICAL" }, { "name": "Miglustat", "type": "DRUG" }, { "name": "Alglucosidase Alfa", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Amicus Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 125, "start_date": "2018-12-04", "completion_date": "2021-01-15", "has_results": true, "last_update_posted_date": "2025-09-11", "last_synced_at": "2026-10-16T07:47:20.054Z", "location_count": 25, "location_summary": "Phoenix, Arizona • Little Rock, Arkansas • Irvine, California + 21 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Irvine", "state": "California" }, { "city": "Gainesville", "state": "Florida" }, { "city": "Tampa", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03729362" }, { "nct_id": "NCT02532322", "title": "Efficacy of Acetaminophen in Posterior Fossa Surgery", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Arnold-Chiari Malformation", "Posterior Fossa Tumors" ], "interventions": [ { "name": "IV acetaminophen", "type": "DRUG" }, { "name": "normal saline", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Children's National Research Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": "12 Years", "sex": "ALL", "summary": "2 Years to 12 Years" }, "enrollment_count": 0, "start_date": "2015-11", "completion_date": "2018-10", "has_results": false, "last_update_posted_date": "2021-04-08", "last_synced_at": "2026-10-16T07:47:20.054Z", "location_count": 1, "location_summary": "Washington D.C., District of Columbia", "locations": [ { "city": "Washington D.C.", "state": "District of Columbia" } ], "official_url": "https://clinicaltrials.gov/study/NCT02532322" }, { "nct_id": "NCT00488774", "title": "An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Colitis, Ulcerative" ], "interventions": [ { "name": "Placebo", "type": "OTHER" }, { "name": "Golimumab 1 mg per kg", "type": "DRUG" }, { "name": "Golimumab 2 mg per kg", "type": "DRUG" }, { "name": "Golimumab 4 mg per kg", "type": "DRUG" } ], "intervention_types": [ "OTHER", "DRUG" ], "sponsor": "Janssen Research & Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 291, "start_date": "2007-08", "completion_date": "2009-05", "has_results": true, "last_update_posted_date": "2013-06-14", "last_synced_at": "2026-10-16T07:47:20.054Z", "location_count": 36, "location_summary": "Orange, California • Roseville, California • Littleton, Colorado + 33 more", "locations": [ { "city": "Orange", "state": "California" }, { "city": "Roseville", "state": "California" }, { "city": "Littleton", "state": "Colorado" }, { "city": "Bristol", "state": "Connecticut" }, { "city": "Tampa", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00488774" }, { "nct_id": "NCT02106546", "title": "Study Comparing Veliparib Plus Carboplatin and Paclitaxel Versus Placebo Plus Carboplatin and Paclitaxel in Previously Untreated Advanced or Metastatic Squamous Non-Small Cell Lung Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Squamous Non-Small Cell Lung Cancer" ], "interventions": [ { "name": "Carboplatin", "type": "DRUG" }, { "name": "Veliparib", "type": "DRUG" }, { "name": "Paclitaxel", "type": "DRUG" }, { "name": "Placebo to veliparib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AbbVie", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "18 Years to 99 Years" }, "enrollment_count": 970, "start_date": "2014-04-10", "completion_date": "2019-11-20", "has_results": false, "last_update_posted_date": "2020-11-17", "last_synced_at": "2026-10-16T07:47:20.054Z", "location_count": 38, "location_summary": "Jonesboro, Arkansas • Los Angeles, California • Aurora, Colorado + 30 more", "locations": [ { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Los Angeles", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Fort Lauderdale", "state": "Florida" }, { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02106546" }, { "nct_id": "NCT01484496", "title": "A Study of Belimumab Administered Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Systemic Lupus Erythematosus" ], "interventions": [ { "name": "Placebo", "type": "BIOLOGICAL" }, { "name": "Belimumab 200 mg SC", "type": "BIOLOGICAL" }, { "name": "Standard therapy", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Human Genome Sciences Inc., a GSK Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 839, "start_date": "2011-11-16", "completion_date": "2015-10-01", "has_results": true, "last_update_posted_date": "2018-06-06", "last_synced_at": "2026-10-16T07:47:20.054Z", "location_count": 82, "location_summary": "Birmingham, Alabama • Peoria, Arizona • Tucson, Arizona + 68 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Peoria", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Jonesboro", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01484496" }, { "nct_id": "NCT00546260", "title": "Safety and Efficacy Study of Adjunctive Antiplatelet Therapy Prior to Primary PCI in Patients With STEMI", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Myocardial Infarction" ], "interventions": [ { "name": "placebo", "type": "DRUG" }, { "name": "PRT060128 Potassium", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Alexion Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 70, "start_date": "2007-11", "completion_date": "2008-07", "has_results": true, "last_update_posted_date": "2026-06-24", "last_synced_at": "2026-10-16T07:47:20.054Z", "location_count": 13, "location_summary": "Tallahassee, Florida • Des Moines, Iowa • Lexington, Kentucky + 10 more", "locations": [ { "city": "Tallahassee", "state": "Florida" }, { "city": "Des Moines", "state": "Iowa" }, { "city": "Lexington", "state": "Kentucky" }, { "city": "Portland", "state": "Maine" }, { "city": "Takoma Park", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00546260" }, { "nct_id": "NCT00122382", "title": "Remission and Joint Damage Progression in Early Rheumatoid Arthritis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Rheumatoid Arthritis" ], "interventions": [ { "name": "Abatacept", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" }, { "name": "methotrexate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bristol-Myers Squibb", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1052, "start_date": "2005-07", "completion_date": "2009-02", "has_results": true, "last_update_posted_date": "2010-11-16", "last_synced_at": "2026-10-16T07:47:20.054Z", "location_count": 19, "location_summary": "Huntsville, Alabama • Huntington Beach, California • Colorado Springs, Colorado + 15 more", "locations": [ { "city": "Huntsville", "state": "Alabama" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Colorado Springs", "state": "Colorado" }, { "city": "Trumbull", "state": "Connecticut" }, { "city": "Indianapolis", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT00122382" }, { "nct_id": "NCT00939913", "title": "Effect of Intravenous Acetadote on Incidence of Contrast Induced Nephropathy", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Nephropathy" ], "interventions": [ { "name": "intravenous NAC", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Ochsner Health System", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 400, "start_date": "2007-01", "completion_date": "2010-05", "has_results": false, "last_update_posted_date": "2009-09-18", "last_synced_at": "2026-10-16T07:47:20.054Z", "location_count": 1, "location_summary": "New Orleans, Louisiana", "locations": [ { "city": "New Orleans", "state": "Louisiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT00939913" }, { "nct_id": "NCT04443920", "title": "Tranexamic Acid for Total Knee Arthroscopy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Blood Loss, Surgical" ], "interventions": [ { "name": "Tranexamic acid (TXA)", "type": "DRUG" }, { "name": "Placebo Normal Saline (NS)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "The Miriam Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 86, "start_date": "2019-10-29", "completion_date": "2021-01-08", "has_results": false, "last_update_posted_date": "2023-06-22", "last_synced_at": "2026-10-16T07:47:20.054Z", "location_count": 1, "location_summary": "Providence, Rhode Island", "locations": [ { "city": "Providence", "state": "Rhode Island" } ], "official_url": "https://clinicaltrials.gov/study/NCT04443920" }, { "nct_id": "NCT03925324", "title": "Serial Infusions of Allogeneic Mesenchymal Stem Cells in Cardiomyopathy Patients With Left Ventricular Assist Device", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Ischemic Heart Disease", "Non-ischemic Cardiomyopathy" ], "interventions": [ { "name": "Human Allogeneic Mesenchymal Bone Marrow Cells (aMBMC)", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "Medstar Health Research Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 4, "start_date": "2019-05-03", "completion_date": "2021-08-16", "has_results": true, "last_update_posted_date": "2022-02-02", "last_synced_at": "2026-10-16T07:47:20.054Z", "location_count": 1, "location_summary": "Washington D.C., District of Columbia", "locations": [ { "city": "Washington D.C.", "state": "District of Columbia" } ], "official_url": "https://clinicaltrials.gov/study/NCT03925324" } ] }